Cargando…
Prevalence of programmed death ligand-1 in patients diagnosed with non-small cell lung cancer in Lebanon
INTRODUCTION: Programmed death ligand-1 expression has been shown to be a good predictor of response to cancer therapy with checkpoint inhibitors. Its expression varies among different tumor types and among non-small cell lung cancer patients with different clinical and demographic characteristics....
Autores principales: | Fakhri, Ghina, Akel, Reem, Khalifeh, Ibrahim, Chami, Hassan, Hajj Ali, Adel, Al Assaad, Majd, Atwi, Haneen, Kadara, Humam, Tfayli, Arafat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442479/ https://www.ncbi.nlm.nih.gov/pubmed/34540227 http://dx.doi.org/10.1177/20503121211043709 |
Ejemplares similares
-
Prognostic indicators of survival in patients with small-cell lung
cancer at a tertiary care center in Lebanon
por: Tfayli, Arafat, et al.
Publicado: (2021) -
Burnout among Lebanese Oncologists: Prevalence and Risk Factors
por: Salem, Rana, et al.
Publicado: (2018) -
Concordance between Immunohistochemistry and Microarray Gene Expression Profiling for Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Statuses in Breast Cancer Patients in Lebanon
por: Fakhri, Ghina B., et al.
Publicado: (2018) -
Prevalence of the epidermal growth factor receptor mutations in lung adenocarcinoma patients from the Middle East region
por: Tfayli, Arafat Hussein, et al.
Publicado: (2019) -
Pulmonary Sarcoidosis Activation following Neoadjuvant Pembrolizumab plus Chemotherapy Combination Therapy in a Patient with Non-Small Cell Lung Cancer: A Case Report
por: Fakhri, Ghina, et al.
Publicado: (2017)